Fabric maker Culp seems to have a rare combination of an exemplary management team and an economic moat, says Morningstar's Todd Wenning.
CORRECTING and REPLACING NuvOx Pharma and the University of Arkansas Initiate Phase Ib/II Clinical Trial in Stroke
Collectors Universe is a neat little business with considerable competitive advantages and an attractive dividend profile, but shares are too pricey right now.
Luggage maker Tumi travels toward moatworthy status in the luxury goods industry.
Monro's acquisition strategy is creating a virtuous cost-advantage cycle, but shares don’t come cheap at the moment, writes Morningstar’s Todd Wenning.
The company has built a leading market share in neurology and newborn care.
Morningstar's Todd Wenning takes a look back at the small-cap stocks featured over the past year.
Fight big-city bias and find a hidden gem.
Flow measurement company Badger Meter's long growth runway and likely narrow moat make it a promising name for patient investors.
U.K.-based Latchways' fall protection products keep workers--and the firm's competitive advantages--safe.